Loading company…
vasopharm develops biopharmaceutical treatments for critical care and neurological conditions.
Established in 1998 and headquartered in Wurzburg, Germany, vasopharm develops biopharmaceutical treatments for critical care and neurology. It raised USD 9.5 mn in a June 2019 growth round from investors including Bayern Kapital and Creathor Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in